Compare BA & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BA | ABT |
|---|---|---|
| Founded | 1916 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 183.0B | 189.6B |
| IPO Year | N/A | N/A |
| Metric | BA | ABT |
|---|---|---|
| Price | $235.88 | $109.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 18 |
| Target Price | ★ $252.00 | $141.00 |
| AVG Volume (30 Days) | 8.7M | ★ 12.7M |
| Earning Date | 01-27-2026 | 01-22-2026 |
| Dividend Yield | N/A | ★ 2.33% |
| EPS Growth | ★ N/A | N/A |
| EPS | 2.48 | ★ 3.72 |
| Revenue | ★ $89,463,000,000.00 | $44,328,000,000.00 |
| Revenue This Year | $11.31 | $8.92 |
| Revenue Next Year | $14.90 | $7.39 |
| P/E Ratio | $95.14 | ★ $29.09 |
| Revenue Growth | ★ 34.50 | 5.67 |
| 52 Week Low | $128.88 | $105.27 |
| 52 Week High | $254.35 | $141.23 |
| Indicator | BA | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 53.52 | 32.39 |
| Support Level | $228.96 | $106.25 |
| Resistance Level | $238.85 | $111.00 |
| Average True Range (ATR) | 7.05 | 2.91 |
| MACD | -2.71 | -0.28 |
| Stochastic Oscillator | 29.26 | 22.01 |
Boeing is a major aerospace and defense firm operating in three segments: commercial airplanes; defense, space, and security; and global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with defense contractors such as Lockheed Martin and Northrop Grumman to create military aircraft, satellites, and weaponry. Global services provides aftermarket support to airlines.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.